Skip to main content
. 2021 Aug 22;71(4):829–838. doi: 10.1007/s00262-021-03035-x

Fig. 1.

Fig. 1

A, B Progression-free survival (PFS) and overall survival (OS) among all patients. C, D PFS and OS according to baseline natural killer (NK) cell activity